Latisse for male pattern baldness (androgenic alopecia)

By Tom at RealSelf on 29 Oct 2010

Allergan, the maker of Latisse is about to start clinical trials for male balding (androgenic alopecia).

According to their filing with the FDA, men from 16 to 64 will be recruited into 2 test groups

1: Experimental bimatoprost Formulation A

One mL dose applied evenly onto pre-specified balding area on scalp - single dose in the am followed by multiple doses daily in the am for 14 days

2: Experimental bimatoprost Formulation B

One mL dose applied evenly onto pre-specified balding area on scalp - single dose in the am, followed by multiple doses daily in the am for 14 days

Contact clinicaltrials@allergan.com

Comments (1)

john razor 28 Feb 2011

This is a great info and i enjoyed this very much.But i have no more knowledge about this topic to share here.